Total Payments
$6,194
2024 Payments
$3,044
Companies
26
Transactions
222
Medicare Patients
1,323
Medicare Billing
$110,770
Payment Breakdown by Category
Food & Beverage$5,909 (95.4%)
Education$284.98 (4.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,909 | 219 | 95.4% |
| Education | $284.98 | 3 | 4.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Dermavant Sciences, Inc. | $908.66 | 41 | $0 (2024) |
| Galderma Laboratories, L.P. | $573.40 | 14 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $566.65 | 15 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $545.96 | 20 | $0 (2024) |
| Lilly USA, LLC | $474.16 | 21 | $0 (2024) |
| PFIZER INC. | $439.90 | 15 | $0 (2024) |
| Incyte Corporation | $384.21 | 15 | $0 (2024) |
| GENZYME CORPORATION | $372.71 | 9 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $358.39 | 12 | $0 (2024) |
| LEO Pharma Inc. | $305.14 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,044 | 119 | Dermavant Sciences, Inc. ($663.68) |
| 2023 | $1,379 | 51 | E.R. Squibb & Sons, L.L.C. ($294.08) |
| 2022 | $942.63 | 31 | PFIZER INC. ($328.62) |
| 2021 | $828.14 | 21 | SUN PHARMACEUTICAL INDUSTRIES INC. ($232.00) |
All Payment Transactions
222 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $10.72 | General |
| Category: Dermatology | ||||||
| 12/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.04 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Lilly USA, LLC | — | Food and Beverage | Cash or cash equivalent | $111.06 | General |
| 12/17/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: Dermatology | ||||||
| 12/16/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: DERMATOLOGY | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $19.02 | General |
| 12/10/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Dermatology | ||||||
| 11/23/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: DERMATOLOGY | ||||||
| 11/23/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $10.81 | General |
| Category: DERMATOLOGY | ||||||
| 11/21/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: Immunology | ||||||
| 11/15/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $89.03 | General |
| Category: Immunology | ||||||
| 11/15/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $74.61 | General |
| Category: DERMATOLOGY | ||||||
| 11/15/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $37.74 | General |
| Category: DERMATOLOGY | ||||||
| 11/14/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $129.79 | General |
| Category: Dermatology | ||||||
| 11/13/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: DERMATOLOGY | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: Dermatology | ||||||
| 11/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $8.04 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $13.40 | General |
| 11/06/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $6.54 | General |
| 10/31/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: DERMATOLOGY | ||||||
| 10/30/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $8.51 | General |
| Category: DERMATOLOGY | ||||||
| 10/29/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $99.66 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 477 | 862 | $134,553 | $38,725 |
| 2022 | 13 | 491 | 786 | $123,141 | $41,911 |
| 2021 | 10 | 297 | 451 | $71,200 | $25,178 |
| 2020 | 2 | 58 | 69 | $13,550 | $4,957 |
Total Patients
1,323
Total Services
2,168
Medicare Billing
$110,770
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 125 | 174 | $37,080 | $11,037 | 29.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 82 | 82 | $22,000 | $6,126 | 27.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 50 | 65 | $18,024 | $5,390 | 29.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 34 | 47 | $14,118 | $3,902 | 27.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 44 | 45 | $11,173 | $3,101 | 27.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 12 | 17 | $7,032 | $2,398 | 34.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 40 | 57 | $9,275 | $1,945 | 21.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $6,299 | $1,876 | 29.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 35 | 295 | $4,719 | $1,550 | 32.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 15 | 20 | $2,696 | $786.90 | 29.2% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 12 | 12 | $2,067 | $587.25 | 28.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 12 | 32 | $69.51 | $26.44 | 38.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 150 | 187 | $33,703 | $12,533 | 37.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 80 | 80 | $19,854 | $6,804 | 34.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 43 | 61 | $15,338 | $5,834 | 38.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 32 | 39 | $10,065 | $3,423 | 34.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 37 | 41 | $11,306 | $3,202 | 28.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $7,721 | $2,718 | 35.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 11 | 15 | $5,169 | $2,014 | 39.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 31 | 44 | $6,589 | $1,878 | 28.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 28 | 215 | $6,239 | $1,123 | 18.0% |
| 11901 | Injection into skin growth, more than 7 growths | Office | 2022 | 11 | 15 | $2,505 | $857.64 | 34.2% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2022 | 11 | 19 | $2,450 | $825.69 | 33.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 12 | 12 | $1,945 | $666.61 | 34.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 21 | 34 | $256.74 | $31.02 | 12.1% |
About Bin Bin Fan
Bin Bin Fan is a Physician Assistant healthcare provider based in Astoria, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/24/2019. The National Provider Identifier (NPI) number assigned to this provider is 1821642216.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Bin Bin Fan has received a total of $6,194 in payments from pharmaceutical and medical device companies, with $3,044 received in 2024. These payments were reported across 222 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($5,909).
As a Medicare-enrolled provider, Fan has provided services to 1,323 Medicare beneficiaries, totaling 2,168 services with total Medicare billing of $110,770. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Astoria, NY
- Active Since 07/24/2019
- Last Updated 11/03/2023
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1821642216
Products in Payments
- VTAMA (Drug) $908.66
- DUPIXENT (Biological) $580.32
- OPZELURA (Drug) $384.21
- Sotyktu (Drug) $358.39
- TALTZ (Drug) $339.42
- EUCRISA (Drug) $329.48
- ADBRY (Biological) $305.14
- AKLIEF (Drug) $248.62
- SKYRIZI (Biological) $233.20
- COSENTYX (Drug) $213.85
- COSENTYX (Biological) $154.12
- ILUMYA (Biological) $149.66
- ORACEA (Drug) $132.60
- Winlevi (Drug) $119.06
- CIBINQO (Drug) $110.42
- TREMFYA (Drug) $104.41
- Otezla (Drug) $89.79
- JUBLIA (Drug) $89.57
- Ilumya (Biological) $73.97
- Zoryve (Drug) $56.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Astoria
Kendel Bennett
Physician Assistant — Payments: $4,462
Physician Assistant $4,462
Efstratia Rabinowitz
Physician Assistant — Payments: $3,683
Physician Assistant $3,683
Vincent Deleon, Pa, PA
Physician Assistant — Payments: $3,456
Physician Assistant $3,456
Gabriella Dutsar, Pa, PA
Physician Assistant — Payments: $3,425
Physician Assistant $3,425
Elvira Khaimov, Pa-C, PA-C
Physician Assistant — Payments: $1,735
Physician Assistant $1,735
Miss. Tara Halpern, Pa, PA
Physician Assistant — Payments: $1,448
Physician Assistant $1,448